[Translation] A randomized, double-blind, parallel-controlled, multicenter clinical trial of JC-5411 capsules versus placebo in the treatment of benign prostatic hyperplasia (BPH)

主要目的：研究口服JC-5411胶囊治疗BPH的临床疗效和安全性；次要目的：研究BPH患者口服JC-5411胶囊群体药代动力学（PPK）和药效动力学（PD）特征。

[Translation]

Primary purpose: To study the clinical efficacy and safety of oral JC-5411 capsules in the treatment of BPH; Secondary purpose: To study the population pharmacokinetic (PPK) and pharmacodynamic (PD) characteristics of oral JC-5411 capsules in patients with BPH.

Start Date-

Sponsor / Collaborator

JC (Wuxi) Co. Inc.

CTR20232507 / RecruitingPhase 1

JC-5411-L 在晚期实体瘤患者中的安全性、耐受性、药代动力学及初步疗效的多中心、开放Ⅰb/Ⅱ 期临床研究

[Translation] A multicenter, open-label, phase Ib/II clinical study on the safety, tolerability, pharmacokinetics and preliminary efficacy of JC-5411-L in patients with advanced solid tumors

主要研究目的： Ⅰb期：评价JC-5411-L在晚期实体瘤患者的安全性和耐受性，探索JC-5411-L的最大耐受剂量（MTD），确定II期临床研究推荐剂量（RP2D）。 Ⅱ期：评价JC-5411-L在卵巢癌患者中的有效性和安全性。次要研究目的：评价JC-5411-L的药代动力学（PK）特征。初步评价JC-5411-L治疗晚期实体瘤患者的疗效。探索性研究目的评价晚期实体瘤患者的肿瘤标本或外周血中的生物标记物水平（包括但不限于p53 蛋白表达水平）与疗效的关系。评价晚期实体瘤患者的GST基因型与疗效的关系。

[Translation]

Main study objectives: Phase Ib: Evaluate the safety and tolerability of JC-5411-L in patients with advanced solid tumors, explore the maximum tolerated dose (MTD) of JC-5411-L, and determine the recommended dose (RP2D) for Phase II clinical studies. Phase II: Evaluate the efficacy and safety of JC-5411-L in patients with ovarian cancer. Secondary study objectives: Evaluate the pharmacokinetic (PK) characteristics of JC-5411-L. Preliminary evaluation of the efficacy of JC-5411-L in the treatment of patients with advanced solid tumors. Exploratory study objectives Evaluate the relationship between the level of biomarkers (including but not limited to p53 protein expression level) in tumor specimens or peripheral blood of patients with advanced solid tumors and the efficacy. Evaluate the relationship between the GST genotype and the efficacy of patients with advanced solid tumors.

Start Date13 Dec 2023

Sponsor / Collaborator

JC (Wuxi) Co. Inc.

NCT00691132 / CompletedPhase 2IIT

Randomized Trial of PEITC as a Modifier of NNK Metabolism in Smokers

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of phenethyl isothiocyanate may prevent lung cancer in people who smoke cigarettes.
PURPOSE: This randomized clinical trial is studying phenethyl isothiocyanate to see how well it works in preventing lung cancer in smokers.

Start Date01 Feb 2009

Sponsor / Collaborator

University of Minnesota

[+1]

100 Clinical Results associated with Nrf2 x HSF1

100 Translational Medicine associated with Nrf2 x HSF1

0 Patents (Medical) associated with Nrf2 x HSF1

Literatures (Medical) associated with Nrf2 x HSF1

01 Oct 2024·Aging Cell

Age‐dependent heat shock hormesis to HSF‐1 deficiency suggests a compensatory mechanism mediated by the unfolded protein response and innate immunity in young Caenorhabditis elegans

Article

Author: Hotzi, Bernadette ; Kovács, Dániel ; Vincze, Viktor Vázsony ; Ahmed, Saqib ; Kovács, Márton ; Barna, János ; Varga, Máté ; Biró, János Barnabás ; Mohammad, Umar ; Sigmond, Tímea ; Vellai, Tibor

AbstractThe transcription factor HSF‐1 (heat shock factor 1) acts as a master regulator of heat shock response in eukaryotic cells to maintain cellular proteostasis. The protein has a protective role in preventing cells from undergoing ageing, and neurodegeneration, and also mediates tumorigenesis. Thus, modulating HSF‐1 activity in humans has a promising therapeutic potential for treating these pathologies. Loss of HSF‐1 function is usually associated with impaired stress tolerance. Contrary to this conventional knowledge, we show here that inactivation of HSF‐1 in the nematode Caenorhabditis elegans results in increased thermotolerance at young adult stages, whereas HSF‐1 deficiency in animals passing early adult stages indeed leads to decreased thermotolerance, as compared to wild‐type. Furthermore, a gene expression analysis supports that in young adults, distinct cellular stress response and immunity‐related signaling pathways become induced upon HSF‐1 deficiency. We also demonstrate that increased tolerance to proteotoxic stress in HSF‐1‐depleted young worms requires the activity of the unfolded protein response of the endoplasmic reticulum and the SKN‐1/Nrf2‐mediated oxidative stress response pathway, as well as an innate immunity‐related pathway, suggesting a mutual compensatory interaction between HSF‐1 and these conserved stress response systems. A similar compensatory molecular network is likely to also operate in higher animal taxa, raising the possibility of an unexpected outcome when HSF‐1 activity is manipulated in humans.

01 Aug 2024·Apoptosis

The significant mechanism and treatments of cell death in heatstroke

Review

Author: Wang, Zixin ; Lv, Jinke ; Liu, Zhifeng ; Zhu, Jie ; Wu, Liangping ; Zhang, Dingshun

With global warming, extreme environmental heat is becoming a social issue of concern, which can cause adverse health results including heatstroke (HS). Severe heat stress is characterized by cell death of direct heat damage, excessive inflammatory responses, and coagulation disorders that can lead to multiple organ dysfunction (MODS) and even death. However, the significant pathophysiological mechanism and treatment of HS are still not fully clear. Various modes of cell death, including apoptosis, pyroptosis, ferroptosis, necroptosis and PANoptosis are involved in MODS induced by heatstroke. In this review, we summarized molecular mechanism, key transcriptional regulation as for HSF1, NRF2, NF-κB and PARP-1, and potential therapies of cell death resulting in CNS, liver, intestine, reproductive system and kidney injury induced by heat stress. Understanding the mechanism of cell death provides new targets to protect multi-organ function in HS.

01 Apr 2024·Biomedicine & Pharmacotherapy

Paeonol promotes longevity and fitness in Caenorhabditis elegans through activating the DAF-16/FOXO and SKN-1/Nrf2 transcription factors

Article

Author: Tao, Mingfang ; Miao, Yuanxin ; Wang, Jinsong ; Chen, Qingchan ; Yi, Qingping ; Li, Rong ; Xu, Yan

Paeonol, as one of the most abundant plant-derived polyphenols, has multiple bioactivities including anti-inflammatory, anti-tumor, and anti-cardiovascular diseases. Nevertheless, the anti-aging effects and related mechanisms of paeonol are rarely reported. In this study, we found that paeonol significantly prolonged the mean lifespan of Caenorhabditis elegans (C. elegans) by 28.49% at a dose of 200 μM. Moreover, paeonol promoted the health of C. elegans by increasing the body bending and pharyngeal pumping rates and reducing the lipofuscin accumulation level. Meanwhile, paeonol induced the expression of stress-related genes or proteins by activating the transcription factors DAF-16/FOXO, SKN-1/Nrf2, and HSF-1, which in turn enhanced oxidative and thermal stress tolerance. The mechanism behind the anti-aging effect of paeonol occurred by down-regulating the insulin/IGF-1 signaling (IIS) pathway. Our findings shed new light on the application of paeonol for longevity promotion and human health.

Analysis

Perform a panoramic analysis of this field.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis